Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM

Globally, chronic noncommunicable diseases rank as the leading cause of morbidity and mortality. Diabetes is reaching high epidemic proportions across the globe. The prevalence of diabetes is increasing in Saudi Arabia, with diabetes affecting 14.1% of the population across all age groups and 28% of those over the age of 30. Date seed intake is one of the best-studied patterns. Previous studies findinds showed that the phenolic compounds in date seeds have blood sugar-lowering properties. There is a lack of data on how date seed diets may affect glycaemia control and cardiovascular risk among Saudi Arabian patients with T2DM. Therefore, randomised controlled trials (RCTs) will be conducted to assess the effects of date seeds on glycaemic control and cardiovascular risk among diabetes patients.

NCT Number	NCT06590519
Lead Sponsor	Universiti Putra Malaysia
Conditions	Type 2 Diabetes Mellitus, Obesity
Enrollment	160 participants
Start Date	2024-07-01
Primary Completion	2025-02-01 (estimated)
Study Completion	2025-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-09-19